---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-109575"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:25:02.737819+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals amends Series A Preferred to grant voting rights at $2.25 conversion price

## Summary
- Amendment grants Series A Preferred holders voting rights on as-converted basis at $2.25/share conversion price.
- Certificate of Amendment filed with Delaware Secretary of State, effective October 11, 2024.
- Required Holders (majority of outstanding preferred) agreed; no additional consideration paid to investors.
- Amendment modifies terms from original July 2023 Securities Purchase Agreement; no other changes to transaction documents.

## SEC filing metadata
- accession: 0001104659-24-109575
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465924109575/0001104659-24-109575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465924109575/tm2426416d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-109575
- JSON: https://secwatch.observer/filing/0001104659-24-109575.json
- Plain text: https://secwatch.observer/filing/0001104659-24-109575.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.